Newsletters and Deep Dive digital magazine
The UK government wants a 'bespoke' deal for pharma - but the EU has other ideas.
After the Nissan deal, pharma is looking for similar reassurances
Patient lives are being transformed by a transitioning from traditional surgical methods to the innovative use of stem cells.
Today, pharma brand planning teams can benefit from technology platforms that aggregate data and automate analyses, helping unlock insights on the market landscape and clinical environment